MAPT and Alzheimer disease: AGEs are involved in the development of the pathological hallmarks of AD, i.e., the accumulation of Aβ is increased by Aβ glycation, and the formation of NFT from phosphorylated tau is accelerated by glycation of the tau protein [55,56].